75690-75-4

Basic information

• Product Name: H-LEU-ARG-PRO-GLY-NH2 2HCL
• Synonyms: LUTEINIZING HORMONE RELEASING HORMONE FRAGMENT 7-10 DIHYDROCHLORIDE;luteinizing hormone releasing hormone*fragment 7-;LUTEINIZING HORMONE RELEASING HORMONE*FR AGMENT 7-10;H-Leu-Arg-Pro-Gly-NH2HCl;LHRH 7-10 SEQUENCE;Leu-Arg-Pro-Gly-NH2, LH-RH Fragment7-10 dihydrochloride;2-(1-((S)-1-((S)-2-((S)-2-amino-4-methylpentanamido)-5-guanidinopentanoyl)pyrrolidine-2-carbonyl)hydrazinyl)acetic acid dihydrochloride;LH-RH Fragment 7-10 dihydrochloride
• CAS NO: 75690-75-4
• Molecular Formula: C19H38Cl2N8O4
• Molecular Weight: 513.46
• Mol File: 75690-75-4.mol

Chemical Properties

• Appearance: /lyophilized powder
• Storage Temp.: −20°C
• CAS DataBase Reference: H-LEU-ARG-PRO-GLY-NH2 2HCL(CAS DataBase Reference)
• NIST Chemistry Reference: H-LEU-ARG-PRO-GLY-NH2 2HCL(75690-75-4)
• EPA Substance Registry System: H-LEU-ARG-PRO-GLY-NH2 2HCL(75690-75-4)

Safety Data

• Hazard Codes: T
• Statements: 60
• Safety Statements: 53-22-36/37/39-45
• WGK Germany: 3
• Hazardous Substances Data: 75690-75-4(Hazardous Substances Data)

Usage

Uses

Used in Oncology:
Leuprorelin is used as a hormone therapy agent for the treatment of hormone-sensitive cancers such as prostate and breast cancer. It is employed to suppress the production of hormones that contribute to the growth of these cancers, thereby helping to control tumor progression and improve patient outcomes.
Used in Gynecology:
In the field of gynecology, Leuprorelin is used as a treatment for endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus. It helps to alleviate the symptoms of endometriosis by reducing the levels of hormones that cause the growth of endometrial tissue.
Used in Combination Therapy:
Leuprorelin is often used in combination with other medications as part of a comprehensive treatment plan for various hormone-related conditions. This approach allows for a more effective management of symptoms and disease progression, enhancing the overall therapeutic outcomes for patients.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Leuprorelin is utilized as an active pharmaceutical ingredient in the formulation of various drug products. It is typically administered as a subcutaneous injection, providing a controlled release of the hormone analog to ensure optimal therapeutic effects.
Overall, H-LEU-ARG-PRO-GLY-NH2 2HCL, or Leuprorelin, plays a significant role in the management of hormone-related medical conditions, offering a targeted approach to treatment that can improve patient outcomes and quality of life.